Leishmania donovani BPK282A1 complete genome, chromosome 14.
Eukaryota; Euglenozoa; Kinetoplastida; Trypanosomatidae; Leishmaniinae; Leishmania.
Whole genome sequencing of multiple Leishmania donovani clinical isolates provides insights into population structure and mechanisms of drug resistance
Submitted (30-MAR-2018) National Center for Biotechnology Information, NIH, Bethesda, MD 20894, USA
Submitted (25-JAN-2011) Aslett M., Pathogen Sequencing Unit, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, Cambridgeshire CB10 1SA, UNITED KINGDOM
PROVISIONAL REFSEQ: This record has not yet been subject to final\nNCBI review. The reference sequence is identical to FR799601.\nData release policy http://www.sanger.ac.uk/legal/#t_2.\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: INSDC submitter\nAnnotation Status :: Full annotation\nAnnotation Pipeline :: Eukaryotic Annotation Propagation Pipeline\n##Genome-Annotation-Data-END##
phosphatidylinositol 3-kinase 2, putative
inositol polyphosphate kinase-like protein, putative
guanine nucleotide-binding protein-like protein
SNF2 family helicase-like protein, putative
calpain-like cysteine peptidase, putative
mitochondrial DNA polymerase I protein C, putative
RNA editing 3' terminal uridylyl transferase 1
ADP/ATP mitochondrial carrier-like protein
ubiquitin/ribosomal protein S27a, putative
phosphoglycan beta 1,3 galactosyltransferase, putative
synaptojanin (N-terminal domain), putative